No Data
No Data
Guichuang Tongqiao-B (02190.HK): The State Drug Administration approved the launch of the Tongqiao Kirin blood flow guide device
On March 25, Gelonghui | Guichuang Tongqiao-B (02190.HK) announced that the Tongqiao Kirin blood flow guidance device independently developed by the Group has been approved for listing by the China Drug Administration (“State Drug Administration”). As the first fully developed remote closed dense mesh stent made in China, the Tsuqiao Kirin blood flow guide device will not only bring new treatment options for intracranial aneurysm treatment; at the same time, it will further enrich the company's product portfolio matrix and enhance the company's influence in the field of neurovascular interventional treatment in China. As of the date of this announcement, the company has obtained approval from the State Drug Administration for a total of 41 products in China. According to the disclosure, blood
Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023
Zylox-Tonbridge Medical Technology (HKG:2190) recorded a 30.7% decline in attributable loss for the year ended Dec. 31, 2023, to 78.7 million yuan from 113.6 million yuan in 2022, a Friday filing on t
Press Release: Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
HANGZHOU, China, March 22, 2024 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market in China, announced its annual financial results for 2023.
Guichuang Tongqiao (02190) has excellent results in 2023: operating revenue increased 58% to 530 million yuan to achieve profit under the adjusted net profit scale
Along with the expansion of revenue scale and overall improvement in operating efficiency, Guichuang Tongqiao achieved an adjusted net profit of 7.03 million yuan in 2023.
ZYLOXTB-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Guichuang Tongqiao-B (02190.HK) plans to hold a board meeting on March 21 to approve the annual results
Gelonghui March 8 | Guichuang Tongqiao-B (02190.HK) announced that the company will hold a board meeting on March 21, 2024 (Thursday) to review and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to deal with other matters.
No Data